FDA Inspection
Grifols Diagnostic Solutions Inc.Grifols Diagnostic Solutions Inc. – FDA Inspection, Jun 28, 2024
Record Details
This FDA Inspection record concerns Grifols Diagnostic Solutions Inc., with an inspection on June 28, 2024, issued by the Los Angeles District Office, covering biologics.
- People
- Antonia L. Panthiruvelil (Issuing Officer)
- Bradley J. Dworak
- Emilia A. Sippert (FDA Personnel)
- Zhugong Liu (Issuing Officer)
View Company Profile
ID · 4b2620f8-49b5-47c9-adf4-36af5fe83100
Inspection Facts
- Inspection number
- 1243819
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Grifols Diagnostic Solutions Inc.
13| Date | Classification | Office | Project area |
|---|---|---|---|
| August 26, 2025 | VAI | Los Angeles District Office | Blood and Blood Products |
| April 3, 2023 | Not classified | Los Angeles District Office | |
| February 17, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 10, 2018 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| November 9, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols Diagnostic Solutions Inc.
- FDA Inspection 1279554 - 2025-08-26
- FDA Inspection 1204974 - 2023-04-03
- FDA Inspection 1162488 - 2022-02-17
- FDA Inspection 1076855 - 2018-12-10
- FDA Inspection 1037913 - 2017-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.